Magnitude and implications of spontaneous hemodynamic variability in primary pulmonary hypertension
Authors:
- Stuart RichSRStuart Rich
- Gilbert E. D'AlonzoGDGilbert E. D'Alonzo
- David R. DantzkerDDDavid R. Dantzker
- Paul S. LevyPLPaul S. Levy
- 1 January 1985
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 55 (1) , 159-163
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Primary Pulmonary Hypertension1984
- Sustained beneficial effect of nifedipine in primary pulmonary hypertensionAmerican Heart Journal, 1983
- Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: Guidelines for determining a pulmonary vasodilator responseAmerican Heart Journal, 1983
- Captopril as treatment for patients with pulmonary hypertension. Problem of variability in assessing chronic drug treatment.Heart, 1982
- The role of hydralazine therapy for pulmonary arterial hypertension of unknown cause.Circulation, 1982
- Primary pulmonary hypertension: effects of nifedipine.Heart, 1980
- Oral Hydralazine Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1980
- Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency.Circulation, 1978
- The variability of arterial pressureAmerican Heart Journal, 1978
- Arterial Blood Pressure Measurements with a Portable Recorder in Hypertensive PatientsCirculation, 1964